William Blair research analyst Sami Corwin was quoted by Healthcare Dive in its story about the Food and Drug Administration leadership’s request to bring back Vinay Prasad to again lead the vaccines and gene therapy division of the organization.
“[W]e think it is possible Dr. Prasad may be less heavy-handed this time around, especially regarding the regulation of products for rare diseases,” Corwin wrote in a note to investors that was cited by the publication.